Description
Geneticin Selective Antibiotic (G418 Sulfate) is produced by the bacterium Micromonospora rhodorangea and acts by binding the ribosome, thus inhibiting protein synthesis in both prokaryotic and eukaryotic cells. Resistance to Geneticin Selective Antibiotic (G418 Sulfate) is conferred by the E. coli APH (3’) - I and APH (3’) - II resistance genes. Gibco Geneticin Selective Antibiotic (G418 Sulfate) is used as a selective antibiotic in the concentration range of 100 - 200 g/ml for bacteria, or 200 - 500 g/ml for most mammalian cells. This product is supplied as a 50 mg/ml solution in water. We offer a variety of cell culture antibiotics for your convenience. Product Use For Research Use Only: Not intended for animal or human diagnostic or therapeutic use. Dual-Site cGMP Manufacturing and Quality Standard Gibco Geneticin Selective Antibiotic (G418 Sulfate) is manufactured at a cGMP compliant facility, located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards. For supply chain continuity, we offer an identical Gibco Geneticin Selective Antibiotic (G418 Sulfate) product made in our Scotland facility (10131-019). This facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standard